Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Operating Expenses (2020 - 2025)

Journey Medical's Operating Expenses history spans 6 years, with the latest figure at $16.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 45.11% year-over-year to $16.5 million, compared with a TTM value of $70.0 million through Dec 2025, changed 0.31%, and an annual FY2025 reading of $70.0 million, changed 0.31% over the prior year.
  • Operating Expenses for Q4 2025 was $16.5 million at Journey Medical, down from $19.2 million in the prior quarter.
  • The five-year high for Operating Expenses was $32.3 million in Q3 2021, with the low at $10.1 million in Q1 2021.
  • Average Operating Expenses over 5 years is $21.0 million, with a median of $20.5 million recorded in 2023.
  • Year-over-year, Operating Expenses surged 250.3% in 2021 and then tumbled 34.42% in 2024.
  • Tracing DERM's Operating Expenses over 5 years: stood at $26.6 million in 2021, then dropped by 2.31% to $26.0 million in 2022, then plummeted by 33.13% to $17.4 million in 2023, then tumbled by 34.42% to $11.4 million in 2024, then skyrocketed by 45.11% to $16.5 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Operating Expenses are $16.5 million (Q4 2025), $19.2 million (Q3 2025), and $17.9 million (Q2 2025).